Similar Items: Bone Health in Type 1 Diabetes: Where We Are Now and How We Should Proceed
- Cystatin C and Its Role in Patients with Type 1 and Type 2 Diabetes Mellitus
- Hypoglycemia Reporting in GLP‐1RA Trials for Type 1 Diabetes: A Critical Gap That Needs To Be Addressed
- The clinical significance of SIGLEC1 mRNA levels derived from peripheral leukocytes in autoimmune thyroid diseases and type 1 diabetes
- Insights from maturity-onset diabetes of the young into impaired insulin secretion in type 2 diabetes
- Circulating CXCL1 in newly diagnosed type 2 diabetes: context-dependent association with inflammatory load and metabolic indices
- Lipid Peroxidation and Antioxidant Status in Nonobese Type 2 Diabetes Mellitus